Full-Time

Senior Manager

Software Engineering, Oncology

Posted on 7/25/2024

BillionToOne

BillionToOne

201-500 employees

Molecular diagnostics for prenatal and oncology testing

Biotechnology
Healthcare

Compensation Overview

$200k - $230kAnnually

+ Equity Options + Industry Leading Company Benefits

Senior

Menlo Park, CA, USA

Full-time onsite position in Menlo Park office.

Category
Backend Engineering
Frontend Engineering
Full-Stack Engineering
Software Engineering
Required Skills
Datadog
Sentry
Python
JavaScript
React.js
Postgres
Docker
AWS
Development Operations (DevOps)
Requirements
  • B.Sc/M.Sc degree in Computer Science or Bioinformatics
  • 5+ years hands-on experience designing, building, and scaling consumer-facing web applications in digital health or diagnostics
  • 3+ years of experience as a hands-on Software Engineering Manager
  • Strong knowledge of web technology across front-end and back-end: Javascript, React, Postgres, Python
  • Strong knowledge of cloud architecture and devops (e.g. Docker, AWS, Sentry, Datadog)
Responsibilities
  • Manage the delivery and operation of high-quality software that enables clinician adoption of BillionToOne’s genetic tests
  • Develop and implement software development processes and best practices to enhance team execution and ensure high-quality products. Use data to identify bottlenecks and improve them
  • Provide hands-on leadership by example through designing, reviewing, and writing code
  • Lead technical planning
  • Collaborate with Design and Product Management to deliver efficient and informative
  • Mentor and guide a team of 3-6 software engineers in their technical and professional development
  • Manage the hiring process to bring on new talent as needed

BillionToOne specializes in molecular diagnostics within the healthcare sector, focusing on prenatal screening and oncology testing. Their proprietary QCT technology allows for the detection and quantification of diseases at a single base-pair resolution, enabling the identification of minute variations in DNA. The company offers two main products: Northstar Select™, which helps determine the best initial therapy for patients, and Northstar Response™, which monitors the effectiveness of that therapy. Unlike many competitors, BillionToOne emphasizes accuracy, efficiency, and accessibility in molecular testing, providing diagnostic services directly to healthcare providers. Their goal is to positively impact healthcare by making molecular testing more reliable and available to everyone.

Company Stage

Series D

Total Funding

$380.2M

Headquarters

Menlo Park, California

Founded

2016

Growth & Insights
Headcount

6 month growth

0%

1 year growth

-2%

2 year growth

1%
Simplify Jobs

Simplify's Take

What believers are saying

  • BillionToOne achieved a billion-dollar valuation with a $130 million funding round.
  • Their new Austin facility will create 1,000 jobs, boosting production and local economy.
  • Recognition as Diagnostics Company of the Year highlights their industry leadership.

What critics are saying

  • Emerging biotech startups could threaten BillionToOne's market share.
  • Rapid technological advancements may render their current technology obsolete.
  • Expansion into new facilities may face operational challenges or delays.

What makes BillionToOne unique

  • BillionToOne's QCT technology detects DNA variations at single base-pair resolution.
  • Their UNITY Fetal Antigen NIPT is the first US cfDNA test for fetal antigen genotyping.
  • They replace invasive amniocentesis with a safe, affordable blood test for prenatal screening.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Competitive pay

Retirement savings package

Parental leave

Free snacks & lunches

Medical, dental, & vision premiums

On campus perks

Free-on-site EV charging

INACTIVE